BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534
15 results:

  • 1. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.
    Gordon K; Gulidov I; Koryakin S; Smyk D; Makeenkova T; Gogolin D; Lepilina O; Golovanova O; Semenov A; Dujenko S; Medvedeva K; Mardynsky Y
    Radiat Oncol; 2021 Dec; 16(1):238. PubMed ID: 34930352
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Role of prenatal magnetic resonance imaging in fetuses with isolated severe ventriculomegaly at neurosonography: A multicenter study.
    Di Mascio D; Khalil A; Pilu G; Rizzo G; Caulo M; Liberati M; Giancotti A; Lees C; Volpe P; Buca D; Oronzi L; D'Amico A; Tinari S; Stampalija T; Fantasia I; Pasquini L; Masini G; Brunelli R; D'Ambrosio V; Muzii L; Manganaro L; Antonelli A; Ercolani G; Ciulla S; Saccone G; Maruotti GM; Carbone L; Zullo F; Olivieri C; Ghi T; Frusca T; Dall'Asta A; Visentin S; Cosmi E; Forlani F; Galindo A; Villalain C; Herraiz I; Sileo FG; Mendez Quintero O; Salsi G; Bracalente G; Morales-Roselló J; Loscalzo G; Pellegrino M; De Santis M; Lanzone A; Parazzini C; Lanna M; Ormitti F; Toni F; Murru F; Di Maurizio M; Trincia E; Garcia R; Bennike Bjørn Petersen O; Neerup L; Sandager P; Prefumo F; Pinelli L; Mappa I; Acuti Martellucci C; Flacco ME; Manzoli L; Giangiordano I; Nappi L; Scambia G; Berghella V; D'Antonio F
    Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():105-110. PubMed ID: 34773875
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Occupational and patients effective radiation doses in dental imaging.
    Tamam N; Almuqrin AH; Mansour S; Elnour A; Musa M; Omer H; Sulieman A; Bradley DA
    Appl Radiat Isot; 2021 Nov; 177():109899. PubMed ID: 34438276
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study.
    Adolph JE; Fleischhack G; Mikasch R; Zeller J; Warmuth-Metz M; Bison B; Mynarek M; Rutkowski S; Schüller U; von Hoff K; Obrecht D; Pietsch T; Pfister SM; Pajtler KW; Witt O; Witt H; Kortmann RD; Timmermann B; Krauß J; Frühwald MC; Faldum A; Kwiecien R; Bode U; Tippelt S
    Neuro Oncol; 2021 Jun; 23(6):1012-1023. PubMed ID: 33331885
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel PTPRZ1-etv1 fusion in gliomas.
    Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
    Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
    Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
    Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence.
    Baysan M; Woolard K; Cam MC; Zhang W; Song H; Kotliarova S; Balamatsias D; Linkous A; Ahn S; Walling J; Belova GI; Fine HA
    Int J Cancer; 2017 Nov; 141(10):2002-2013. PubMed ID: 28710771
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.
    Gleize V; Alentorn A; Connen de Kérillis L; Labussière M; Nadaradjane AA; Mundwiller E; Ottolenghi C; Mangesius S; Rahimian A; Ducray F; ; Mokhtari K; Villa C; Sanson M
    Ann Neurol; 2015 Sep; 78(3):355-74. PubMed ID: 26017892
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of Kit and etv1 in restricted brain regions supports a brain-cell progenitor as an origin for cranial germinomas.
    Tan C; Scotting P
    Cancer Genet; 2015 Mar; 208(3):55-61. PubMed ID: 25736805
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
    Labussière M; Di Stefano AL; Gleize V; Boisselier B; Giry M; Mangesius S; Bruno A; Paterra R; Marie Y; Rahimian A; Finocchiaro G; Houlston RS; Hoang-Xuan K; Idbaih A; Delattre JY; Mokhtari K; Sanson M
    Br J Cancer; 2014 Nov; 111(10):2024-32. PubMed ID: 25314060
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with etv1 expression in melanoma brain metastases.
    Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
    Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression.
    Alder D; Braun M; Nikolov P; Boehm D; Scheble V; Menon R; Fend F; Kristiansen G; Perner S; Wernert N
    Hum Pathol; 2012 Nov; 43(11):1910-6. PubMed ID: 22569213
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases.
    Jagannathan J; Yen CP; Ray DK; Schlesinger D; Oskouian RJ; Pouratian N; Shaffrey ME; Larner J; Sheehan JP
    J Neurosurg; 2009 Sep; 111(3):431-8. PubMed ID: 19361267
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.